Literature DB >> 8448143

Expression of a cocaine-sensitive norepinephrine transporter in the human placental syncytiotrophoblast.

S Ramamoorthy1, P D Prasad, P Kulanthaivel, F H Leibach, R D Blakely, V Ganapathy.   

Abstract

Maternal-facing brush border membrane vesicles isolated from normal term human placentas were found to accumulate norepinephrine in a concentrative manner in the presence of an inwardly directed NaCl gradient. Both Na+ and Cl- were obligatory for maximal uptake. The NaCl-dependent norepinephrine uptake was further stimulated by the presence of K+ or an acidic pH in the intravesicular medium. The uptake process was electrogenic, being stimulated by an inside-negative membrane potential, and this characteristic was observed in the absence as well as in the presence of K+ inside the vesicles. Kinetic analyses revealed that one Na+ and one Cl- were involved per transport of one norepinephrine molecule. The apparent Michaelis-Menten constant for norepinephrine was 104 +/- 5nM. The uptake process exhibited higher affinity for dopamine than for norepinephrine but had low affinity for serotonin and histamine. The uptake of norepinephrine was inhibited very effectively by nomifensine, desipramine, imipramine, and cocaine, but much less effectively by bupropion and GBR 12909. Northern blot analysis with the cDNA of the human (SK-N-SH cell) norepinephrine transporter as the probe revealed that the human placenta contained two mRNAs, 5.8 and 3.6 kb in size, which hybridized to the probe. The JAR human placental choriocarcinoma cells were found unable to accumulate norepinephrine in a NaCl-dependent manner. These cells were also found not to contain mRNAs which hybridized to the norepinephrine cDNA probe in northern blot. It is concluded that the human placental syncytiotrophoblast expresses a cocaine-sensitive norepinephrine transporter and that these findings may be directly relevant and important to the clinical complications of maternal cocaine abuse during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448143     DOI: 10.1021/bi00056a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

Review 1.  Monoamine oxidases in development.

Authors:  Chi Chiu Wang; Ellen Billett; Astrid Borchert; Hartmut Kuhn; Christoph Ufer
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Patch-clamp and amperometric recordings from norepinephrine transporters: channel activity and voltage-dependent uptake.

Authors:  A Galli; R D Blakely; L J DeFelice
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 3.  Bioenergetics of neurotransmitter transport.

Authors:  G Rudnick
Journal:  J Bioenerg Biomembr       Date:  1998-04       Impact factor: 2.945

4.  A variant of the bovine noradrenaline transporter reveals the importance of the C-terminal region for correct targeting to the membrane and functional expression.

Authors:  L D Burton; A G Kippenberger; B Lingen; M Brüss; H Bönisch; D L Christie
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 5.  Transendothelial Transport and Its Role in Therapeutics.

Authors:  Ravi Kant Upadhyay
Journal:  Int Sch Res Notices       Date:  2014-08-27

6.  The NH(2)-terminus of norepinephrine transporter contains a basolateral localization signal for epithelial cells.

Authors:  H H Gu; X Wu; B Giros; M G Caron; M J Caplan; G Rudnick
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

7.  Expression and function of variants of human catecholamine transporters lacking the fifth transmembrane region encoded by exon 6.

Authors:  Chiharu Sogawa; Chieko Mitsuhata; Kei Kumagai-Morioka; Norio Sogawa; Kazumi Ohyama; Katsuya Morita; Katsuyuki Kozai; Toshihiro Dohi; Shigeo Kitayama
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

Review 8.  Drug transporters in the human blood-placental barrier.

Authors:  Kirsi Vähäkangas; Päivi Myllynen
Journal:  Br J Pharmacol       Date:  2009-09-25       Impact factor: 8.739

9.  Functional consequences of homo- but not hetero-oligomerization between transporters for the biogenic amine neurotransmitters.

Authors:  A M Kocabas; G Rudnick; F Kilic
Journal:  J Neurochem       Date:  2003-06       Impact factor: 5.372

Review 10.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.